Keywords: abbott, files, first, marketing, applications, arthritis, drug

Abbott files first marketing applications for arthritis drug adalimumab

Article | 15 April 2002

Print This

Abbott Laboratories has submitted its first marketing applications, inboth the USA and the European Union, for adalimumab (also known as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in